genomic analysis

Tempus AI shares jumped 7.3% to $49.34 after 31 cancer research abstracts were accepted for AACR conference, though analyst coverage turns cautious.

Nvidia and Droplet Biosciences partnership cuts cancer detection to 24 hours post-surgery using GPU-accelerated genomics, reducing computational time 92% and costs 30%.